We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Gynaecological
Digital Poster
Clinical
Assessing 4 optimization strategies for altered brachytherapy applications in carcinoma cervix
Bhooshan Purushottam Zade, India
E25-48
Are published bone marrow dose constraints appropriate when intensifying adjuvant treatment for patients with high-risk endometrial cancer?
Raouia Ben Amor, Tunisia
E25-643
Immune cell function during and after bone marrow sparing versus non-bone marrow sparing EBRT in cervical cancer
Anouk Corbeau, The Netherlands
E25-655
Stereotactic Body Radiation therapy (SBRT) with MRI-Linac in oligometastatic gynaecological cancer patients: a systematic review
Donato Pezzulla, Italy
E25-703
effects of extraperitoneal LND and diagnostic imaging methods on survival in staging before primary radiotherapy in locally advanced cervical cancers
hamit başaran, Turkey
E25-785
Spatial analysis of ovarian transposition and its impact on radiation exposure during cervical cancer treatment
Catarina Santana, Portugal
E25-827
Adjuvant Chemotherapy Versus Chemotherapy and Radiation Therapy in Patients With Stage III Endometrial Cancer: A Propensity Score Matching Study
Janjira Petsuksiri, Thailand
E25-831
A systematic review of the impact of pelvic radiotherapy on the sexual health of gynecological cancer patients
Lara Hathout, USA
E25-926
Clinical implementation of the EMBRACE II protocol for CBCT-based ART of gynecological cancers
David Dechambre, Belgium
E25-955
Recurrence rates and patterns in locally advanced cervical cancer in the IMRT era: a single institution experience
Bayan Malakouti-Nejad, Canada
E25-1175
Modern chemoradiation followed by radical surgery in patients with locally advanced cervical cancer: the LARA 4 phase II study
Gabriella Macchia, Italy
E25-1336
Online adaptive radiotherapy for postoperative patients with endometrial cancer.
Liselotte ten Asbroek, The Netherlands
E25-208
Are We Addressing Sexual Health in Gynaecological Patients, Including LGBTQIA+ Individuals? Italian Survey Results on behalf of MITO & AIRO-GYN
Ester Orlandi, Italy
E25-1479
Sexual quality of life after definitive radio (chemo) therapy and CT image-guided adaptive brachytherapy for locally advanced cervical cancer
Beatrice Anghel, Romania
E25-1581
assessment of acute toxicity in daily online adaptive radiotherapy for cervical cancer
Guangyu Wang, China
E25-1604
Quality of Life and sexual health in cervical cancer: early stages and locally advanced.
Sofia Cordoba Largo, Spain
E25-1672
Active Bone Marrow Delineation in Pelvic Radiotherapy Using 3D Deep Learning Segmentation: A Multi-Center Retrospective Study
Zhe Zhang, China
E25-1749
Impact of adjuvant radiotherapy on fatigue in gynaecological cancer patients: a 20-years single institutional experience in 501 patients
Paolo Bonome, Italy
E25-1797
Evaluation of molecular signature predictive power for response to neoadjuvant chemoradiotherapy in patients with locally advanced cervical cancer
Gabriella Macchia, Italy
E25-2072
Long-term Result of Adjuvant Small Pelvis EBRT for Early-stage Cervical Cancer with Intermediate Risk Factors
ferah yildiz, Turkey
E25-2090
Quality of life and sexual health in endometrial carcinoma patients treated with adjuvant radiotherapy
Jesus Romero Fernandez, Spain
E25-2224
Is Bowel Dose a Barrier to Simultaneous Integrated Dose Escalation in Pelvic Malignancies?
Swetha Suresh, India
E25-2288
Update of Incidence, Survival, and Initial Treatment in Patients With Cervical Cancer in the United States?From 2000 to 2021
Xiaojing Yang, China
E25-227
Impact of waiting time for radiotherapy in patients with cervical cancer at Tertiary care hospital: A retrospective study.
AKSHATHA S, India
E25-2300
Integrating novel and classical prognostic factors in locally advanced cervical cancer: a machine learning-based predictive model (ESTHER Study).
Silvia Cammelli, Italy
E25-2358
Tumor volume evolution in women treated with 1.5T MR-guided radiotherapy for cervical cancer
Perla Zidane, France
E25-2473
A single-institution retrospective analysis of prophylactic extended field radiation therapy with chemotherapy in FIGO stage IB to IVA cervical cancer
Karen Anne Aguirre-Meneses, Philippines
E25-2516
Fast and robust on-line adaptive hyperthermia planning to ensure consistent thermoradiotherapy treatment quality in patients with pelvic tumours.
HP Kok, The Netherlands
E25-2573
The efficacy,feasibility and safety study of HAART combined with radiotherapy in HIV-infected women with locally-advanced cervical cancer
Wu Xingrao, China
E25-2663
SBRT TREATMENT IN OLIGOMETASTATIC OVARIAN CANCER
Jesus Romero Fernandez, Spain
E25-2964
Sleep disorders during radiotherapy and their impact on quality of life in gynecological cancers
boutaina agdi, Morocco
E25-3137
Application of interstitial brachytherapy using individual curved-needle in treatment of recurrent gynecological tumors
Zheng Zeng, China
E25-3177
Evaluation of clinical response and toxicity of hypofractionated radiotherapy regimen versus conventional regimen in locally advanced cervical cancer
José Alberto Calderón Cordova, Mexico
E25-3201
Clinical target volume delineation variability in endometrial cancer patients - Serbian National study
Marija Živković Radojević, Serbia
E25-435
Prognostic impact and validation of new molecular classification in endometrial cancer patients
Mehmet Varol, Turkey
E25-3424
Prognostic role of the mismatch repair deficiency in patients with endometrial cancer received radiotherapy
Abdurahman Kuzhan, Turkey
E25-3475
Does lymphovascular space invasion affect prognosis in uterine confined endometrioid carcinoma?
Ankita Mallick, India
E25-3500
comparing the new FIGO staging system for endometrial cancer to the previous 2009 system in a monocentric cohort of patients treated with radiotherapy
Federica Piccolo, Italy
E25-3551
First institutional report from Argentina on stereotactic body radiotherapy (SBRT) in patients with oligometastatic gynecologic cancer
Gustavo Ferraris, Argentina
E25-3574
Higher disease-free survival observed for complete response after SBRT in oligometastatic gynecologic tumors
Andrei Fodor, Italy
E25-3605
Unsupervised Clustering Analysis of Laboratory Data and Inflammatory Indices in Locally Advanced Cervical Cancer Treated with Chemoradiation
Silvia Cammelli, Italy
E25-3773
Treatments for endometrial cancer and availability of molecular data in the current Italian scenario: a survey from the Gynecology Study Group of AIRO
Gabriella Macchia, Italy
E25-3954
Outcomes of locally advanced cervical cancer in South America: analysis of a bicentric cohort
Gabriel Lazcano Álvarez, Chile
E25-4017
IMRT by Tomotherapy with concurrent weekly cisplatin followed by Brachytherapy HDR in locally advance cervical cancer (prospective study).
Sofiane Mellouk, Algeria
E25-447
Definitive Radiotherapy for Vulvovaginal Squamous Cell Carcinoma: Clinical Outcomes from a Single-Center Retrospective Study
PITTAYA DANKULCHAI, Thailand
E25-4030
Association between body composition and survival in gynecological cancer patients undergoing radiotherapy
Artemis Bouzaki, United Kingdom
E25-4128
External beam radiotherapy boost in gynecological tumours in which brachytherapy proves infeasible
Diana Guevara Barrera, Spain
E25-4227
Impact of Bone Marrow Dose from Chemoradiation on Acute Hematologic Toxicities in Locally Advanced Cervical Cancer with VMAT Technique
Ambedkar Yadala, India
E25-4267
Vaginal Stenosis as a Complication of Radiation Therapy in Cervical Cancer: Incidence and Predictive Factors – A retrospective study of 250 patients
Ikram L'Ochi, Morocco
E25-4359
Place of Radiotherapy and concomitant radio-chemotherapy in the treatment of vaginal cancer
boutaina agdi, Morocco
E25-4399
Treatment Outcomes and Survival Analysis of Cervical Cancer Patients at a Tertiary Oncology Center in Uganda
Solomon Kibudde, Uganda
E25-4400
Oncologic outcomes and toxicity profile of EBRT and HDR-BT in locally advanced cervical cancer: A single center retrospective study.
Frandeina Pinto Guevara, Spain
E25-4405
Compliance with ketogenic diet in patients undergoing radiotherapy for gynaecological cancers: a prospective, randomized, mono-centric study
ROSA AUTORINO, Italy
E25-4427
Predictive survival score in intermediate and low risk endometrial carcinoma: A tool for optimizing treatment in low-resource settings
Emna Boudhina, Tunisia
E25-4437
Association of long-term treatment outcomes with changes in PET/MRI characteristics in locally advanced cervical cancer patients.
Radovan Vojtíšek, Czech Republic
E25-503
Evaluating the incidence of sacral insufficiency fractures in gynecologic cancers treated with the VMAT technique.
ANDREA GRAU MORENILLA, Spain
E25-4456
Impact of molecular classification of endometrial cancer: single-center prospective cohort study
Alessia Surgo, Italy
E25-4498
Implementing nutritional screening in radiation oncology consultation for gynecological cancer
Carlos Garcia Zanoguera, Spain
E25-4576
Geriatric patient with gynaecological neoplasia: a current challenge in adjuvant radiation treatment
Francesca Gessoni, Italy
E25-4605
Could surgery address oncological disparities in advanced cervical cancer patients lacking access to modern image-guided brachytherapy?
Raouia Ben Amor, Tunisia
E25-612
Assessment of post-traumatic stress disorder in patients undergoing radiotherapy for gynecological cancer
Amal Chamsi, Tunisia
E25-618
Impact of innovative techniques on cervical cancer therapeutic results
Nejla Fourati, Tunisia
E25-627